Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase 3 4 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Prostatic Neoplasms 2 Neoplasm, Residual 2 Lymphoma 2 Esophageal Stenosis 2 Prostate Cancer Metastatic 1 Polycystic Ovary Syndrome 1 Myasthenia Gravis 1 Metastatic Castration-Resistant Prostate Cancer 1 Mediastinal Neoplasms 1 Lymphoma, Large-Cell, Anaplastic 1 Infertility 1 Hodgkin Disease 1 Hemangioma 1 Esophageal Neoplasms 1 Burkitt Lymphoma 1 Barrett Esophagus 1 Adrenal Insufficiency 1

Interventions

Brentuximab Vedotin 3 Vinblastine 2 Radiotherapy 2 Cyclophosphamide 2 tislelizumab 1 sintilimab 1 prednylidene 1 Watchful Waiting 1 Thiotepa 1 Prednisolone 1 Pentoxifylline 1 Filgrastim 1 Doxorubicin 1 Dacarbazine 1 Bendamustine Hydrochloride 1 Antilymphocyte Serum 1 ABVD protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hodgkin Disease × Prednisolone × Clear all

NCT01088750 2023-12-13

EuroNetLP1

Martin-Luther-Universität Halle-Wittenberg

Phase 4 Completed

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡